Aptus Pharma share news and announcements
BSE: 544529Pharmaceuticals & BiotechnologySmall Cap
Last close ₹491.50down ₹10.00 (1.99%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹501.50.
52-week range of traded prices to 23 Oct 2026
₹48.10Low, 27 Oct 2025₹510.90High, 23 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹843 Cr2,265th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 21 Oct 2026
- 106.0
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 21 Oct 2026
- 29.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 21 Oct 2026
- 31.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026. The filing of 21 Oct 2026
- 0.43
- Volume, BSEVolume. Shares traded on the last trading day.
- 18,000
Aptus Pharma board meetings
16 filed, newest first.
Oct 2026
16 Oct · Board meeting
Meeting on 20 Oct 2026: half yearly results
Aug 2026
17 Aug · Board meeting
12 Aug · Board meeting
Meeting on 17 Aug 2026: annual general meeting5 Aug · Board meeting
Meeting on 8 Aug 2026: preferential issue of shares
Jun 2026
12 Jun · Board meeting
9 Jun · Board meeting
Meeting on 12 Jun 2026: preferential issue of shares
Apr 2026
20 Apr · Board meeting
Meeting on 27 Apr 2026: audited results
Mar 2026
24 Mar · Board meeting
17 Mar · Board meeting
Meeting on 24 Mar 2026: bonus issue and increase in authorised capital
Nov 2025
3 Nov · Board meeting
Meeting on 10 Nov 2025: half yearly results